Recombinant multi-species SLC25A5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC25A5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the mitochondrial carrier subfamily of solute carrier protein genes. The product of this gene functions as a gated pore that translocates ADP from the cytoplasm into the mitochondrial matrix and ATP from the mitochondrial matrix into the cytoplasm. The protein forms a homodimer embedded in the inner mitochondria membrane. Suppressed expression of this gene has been shown to induce apoptosis and inhibit tumor growth. The human genome contains several non-transcribed pseudogenes of this gene.[provided by RefSeq, Jun 2013]
The Alternative Names of target: 2F1,AAC2,ADP,ADP/ATP translocase 2,ANT2,ATP carrier protein,ATP carrier protein 2,Adenine nucleotide translocator 2 (ANT 2),Ant2,SLC25A5,Slc25a5,Solute carrier family 25 member 5,T2,T3,fibroblast isoform

Target products collectionGo to SLC25A5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1688-Ag-1/ GM-Tg-hg-IP1688-Ag-2 Human SLC25A5 protein Human
GM-Tg-rg-IP1688-Ag-1/ GM-Tg-rg-IP1688-Ag-2 Rat SLC25A5 protein Rat
GM-Tg-mg-IP1688-Ag-1/ GM-Tg-mg-IP1688-Ag-2 Mouse SLC25A5 protein Mouse
GM-Tg-cynog-IP1688-Ag-1/ GM-Tg-cynog-IP1688-Ag-2 Cynomolgus/Rhesus macaque SLC25A5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1688-Ag-1/ GM-Tg-felg-IP1688-Ag-2 Feline SLC25A5 protein Feline
GM-Tg-cang-IP1688-Ag-1/ GM-Tg-cang-IP1688-Ag-2 Canine SLC25A5 protein Canine
GM-Tg-bovg-IP1688-Ag-1/ GM-Tg-bovg-IP1688-Ag-2 Bovine SLC25A5 protein Bovine
GM-Tg-equg-IP1688-Ag-1/ GM-Tg-equg-IP1688-Ag-2 Equine SLC25A5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1688-Ag-1/ GM-Tg-hg-IP1688-Ag-2; GM-Tg-rg-IP1688-Ag-1/ GM-Tg-rg-IP1688-Ag-2;
GM-Tg-mg-IP1688-Ag-1/ GM-Tg-mg-IP1688-Ag-2; GM-Tg-cynog-IP1688-Ag-1/ GM-Tg-cynog-IP1688-Ag-2;
GM-Tg-felg-IP1688-Ag-1/ GM-Tg-felg-IP1688-Ag-2; GM-Tg-cang-IP1688-Ag-1/ GM-Tg-cang-IP1688-Ag-2;
GM-Tg-bovg-IP1688-Ag-1/ GM-Tg-bovg-IP1688-Ag-2; GM-Tg-equg-IP1688-Ag-1/ GM-Tg-equg-IP1688-Ag-2
Products Name SLC25A5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SLC25A5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC25A5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.